Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow Post author:Sam Post published:November 29, 2017 Post category:BioPharma Sanofi’s setback could open the door for rival drugmaker Takeda. Source: BioSpace You Might Also Like World's Top 5 Best-Selling Drugs in 2017 December 17, 2017 The 7 Best Life Science Companies to Work for in 2018 January 10, 2018 3 Top Drugmakers Leading Lung Cancer R&D Right Now November 19, 2017
